Tiazotic Acid

Tiazotic Acid

SCHEMBL6409061

Cc1nnc(SCC(=O)O)[nH]1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.51
CSNK2A2 P19784 2/20 0.46
CSNK2A1 P68400 2/20 0.46
ALDH1A1 P00352 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
KMT2A Q03164 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
GAA P10253 1/20 0.44
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
CSNK2B P67870 1/20 0.42
ATM Q13315 1/20 0.41
MEN1 O00255 1/20 0.41
PRKAG1 P54619 1/20 0.41
PRKAA2 P54646 1/20 0.41
PRKAB1 Q9Y478 1/20 0.41
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408206 0.79 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2KMT2AL3MBTL1GAA
SCHEMBL17214887 0.74 ALDH1A1 (0.41) POLBCSNK2A2CSNK2A1ALDH1A1TDP1
SCHEMBL11887741 0.74 TYMP (0.57) ALDH1A1TDP1KMT2AGAAKDM4E
SCHEMBL6405997 0.74 KMT2A (0.39) POLBCSNK2A2CSNK2A1ALDH1A1TDP1
SCHEMBL17214763 0.73 KMT2A (0.42) POLBALDH1A1TDP1SMN1; SMN2KMT2A
SCHEMBL17214848 0.72 GAA (0.44) POLBCSNK2A2CSNK2A1ALDH1A1TDP1
SCHEMBL14478829 0.72 LMNA (0.63) POLBALDH1A1SMN1; SMN2KMT2AL3MBTL1
SCHEMBL17214845 0.72 ALDH1A1 (0.44) POLBCSNK2A2CSNK2A1ALDH1A1TDP1
SCHEMBL17214886 0.72 KMT2A (0.41) POLBALDH1A1TDP1SMN1; SMN2KMT2A
SCHEMBL17213026 0.71 GRK6 (0.46) POLBALDH1A1TDP1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT POLB 854/4885CSNK2A2 3286/4885CSNK2A1 3443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.